(CLOSED) Brain Research Foundation: 2019 Fay/Frank Seed Grant

Sponsor Name: 
Brain Research Foundation
Amount: 
$80,000.00
Description of the Award: 

Brain Research Foundation has invited Penn State to nominate one faculty member (Assistant or Associate Professor) to submit a Letter of Intent (LOI) for the Fay/Frank Seed Grant Program.

Brain Research Foundation’s Annual Seed Grant Program was initiated in 1981. The purpose of our program is to provide start-up monies for new research projects in the field of neuroscience that will likely lead to extramural funding from the National Institutes of Health (NIH) or other outside funding sources.

Brain Research Foundation’s Scientific Review Committee will review the seed grant proposals and make recommendations for funding to the Foundation. The Committee consists of senior scientists broadly representing the various neuroscience-related programs. A representative of Brain Research Foundation is also present when the Committee meets.

Objectives: The objective of the BRF Seed Grant Program is to support new and innovative projects, especially those of junior faculty, who are working in new research directions. BRF Seed Grant awards are not intended to supplement existing grants.

Funding and award period: Each total grant is limited to $80,000 (direct costs) for a two year grant period. The first grant payment of $40,000 will be made upon completion of the Seed Grant Acceptance Form (June 2019). The final payment of $40,000 will be made contingent upon receipt of a Preliminary Progress and Financial Report (June 2020). Funds must be utilized within the grant period.

Funding Specifics:
1.) Funding is to be directed at pilot research projects that are both innovative and will likely lead to successful grant applications to NIH and other public and private funding entities.

2.) Assistant Professor – Junior faculty with a new research project that will generate pilot data that will lead to RO1 funding or a comparable outside grant will be first priority. Must provide abstract and specific aims for current grants and indicate if there is any overlap.

3.) Associate Professor  Faculty who are pursuing new research directions. Must explain how the project is a new research direction. Must provide abstract and specific aims for current grant(s) and indicate if there is any overlap.

4.) A new technique is not considered a new direction unless it pertains to a different area of study.

5.) Seed Grants are NOT to be used for bridge funding between grants.

Limit (Number of applicants permitted per institution): 
1
Sponsor Final Deadline: 
Jan 08, 2019
OSVPR Application or NOI Instructions: 

APPLICATION MATERIALS
The following components are required for the internal downselect process,submitted as a single collated PDF document:
1) Brief summary of program project (2 page maximum, 10 pt. font minimum)

2) List of current grants (include abstracts, specific aims, and indicate if there is any overlap)

3) Biographical sketch (using current NIH format) with other support page (5 page maximum)

The Foundation Relations Office is the designated institutional contact responsible for communicating with the Foundation and is collaborating with Limited Submissions on the internal downselect process. Questions concerning foundation-related questions should be directed to Jessica Kiely, Associate Director of Foundation Relations (717-531-0003 ext. 281713 or jkiely1@pennstatehealth.psu.edu).

To be considered as a Penn State institutional nominee, please submit a notice of intent by the date provided directly below.
This limited submission is in downselect: 
Penn State may only submit a specific number of proposals to this funding opportunity. The number of NOIs received require that an internal competition take place, thus, a downselect process has commenced. No Penn State researchers may apply to this opportunity outside of this downselect process. To apply for this limited submission, please use this link:
OSVPR Downselect Deadline: 
Friday, November 16, 2018 - 4:00pm
Notes: 
Meadowcroft, Mark (Neurosurgery, College of Medicine) 12/18/18